Intraperitoneal cisplatin with regional hyperthermia in advanced ovarian cancer: pharmacokinetics and cisplatin–DNA adduct formation in patients and ovarian cancer cell linesP.J.M. van de Vaart, Adrian C. Begg, Jos H. Beijnen et al.|European Journal of Cancer|1998Cited by 233
Intratumoural administration of cisplatin in slow-release devices: II. pharmacokinetics and intratumoural distributionMarc J. M. Deurloo, Adrian C. Begg, Wim Kop et al.|Cancer Chemotherapy and Pharmacology|1991Cited by 49
Antibodies against cisplatin-modified DNA and cisplatin-modified (di) nucleotidesP. M. A. B. Terheggen, L. Den Engelse, Adrian C. Begg et al.|Cancer Chemotherapy and Pharmacology|1991Cited by 27